Working… Menu
Trial record 1 of 1 for:    NGF0120
Previous Study | Return to List | Next Study

Study to Evaluate OXERVATE™ in Patients With Stage 1 Neurotrophic Keratitis (DEFENDO)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04485546
Recruitment Status : Recruiting
First Posted : July 24, 2020
Last Update Posted : January 6, 2021
Dompé US
Information provided by (Responsible Party):
Dompé Farmaceutici S.p.A

No Study Results Posted on for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : August 2021